Exploring Regulatory, Inspection, and Cultural PV Trends in APAC

Explore evolving APAC PV trends: cultural diversity, CBDT rules, inspections, RMPs, outsourcing, and vendor audit best practices.

In our latest discussion, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, is joined by Theo Giannou and Wee Chuan Lau from Bloom Agents, a regional pharmacovigilance service provider with over 30 years’ experience across Asia-Pacific (APAC).

They share timely insights on the evolving PV landscape in APAC, including:

  • Navigating cultural diversity across the region
  • Digital transformation and tightened safety reporting
  • China’s 2024 CBDT rules and implications for cross-border ICSR transfers
  • Inspection trends across Japan, Australia, China, Southeast Asia and Malaysia
  • Local risk-management strategies and country-specific RMP adaptations
  • Best practices for PV outsourcing, distributor delegation and vendor audits
Choosing the Right QPPV Partner for EU and Global Compliance

Choosing the Right QPPV Partner for EU and Global Compliance

Pharmacovigilance outsourcing has become crucial for biotech companies to remain compliant and safeguard patients. When you bring a drug to market in Europe or globally, your Qualified Person for Pharmacovigilance (QPPV) serves as your first line of defense. The right...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information